Provectus Biopharmaceuticals, Inc.
PVCT
$0.0749
-$0.0042-5.31%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 27.00% | 63.95% | 533.45% | 64.44% | -76.50% |
Total Receivables | -- | -- | -- | 700.00% | -80.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -63.94% | 234.02% | -30.64% | -14.55% | -27.11% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -54.25% | -57.28% | -23.76% | -24.84% | -21.63% |
Total Current Assets | -33.51% | 28.53% | -5.02% | -20.68% | -26.08% |
|
|||||
Total Current Assets | -33.51% | 28.53% | -5.02% | -20.68% | -26.08% |
Net Property, Plant & Equipment | -43.05% | -29.76% | -25.27% | -19.94% | -16.43% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -33.79% | 25.47% | -6.35% | -20.63% | -25.52% |
|
|||||
Total Accounts Payable | -32.77% | -19.87% | 4.47% | -3.51% | -18.25% |
Total Accrued Expenses | 0.36% | 38.78% | -52.20% | 8.98% | -4.11% |
Short-term Debt | -39.66% | 86.88% | 0.55% | -42.43% | -31.28% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -17.65% | 10.69% | -8.42% | -1.80% | 9.87% |
Total Finance Division Other Current Liabilities | -82.89% | -4.08% | -23.86% | -35.65% | -24.97% |
Total Other Current Liabilities | -82.89% | -4.08% | -23.86% | -35.65% | -24.97% |
Total Current Liabilities | -17.78% | 12.06% | -25.63% | -1.72% | -5.56% |
|
|||||
Total Current Liabilities | -17.78% | 12.06% | -25.63% | -1.72% | -5.56% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -39.66% | 86.88% | 0.55% | -42.43% | -31.28% |
Capital Leases | -- | -- | -- | -- | -49.80% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -17.78% | 12.06% | -25.63% | -1.87% | -5.68% |
|
|||||
Common Stock & APIC | 0.79% | 0.73% | 1.26% | 0.32% | 0.26% |
Retained Earnings | -0.44% | -0.93% | -0.40% | -0.33% | -0.20% |
Treasury Stock & Other | 0.00% | -0.83% | 0.50% | 0.17% | -0.66% |
Total Common Equity | 14.33% | -9.87% | 27.76% | -0.71% | 1.88% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 2.13% | 0.71% | 7.69% | -43.48% | 1.32% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 2.13% | 0.71% | 7.69% | -43.48% | 1.32% |
|
|||||
Total Common Equity | 14.33% | -9.87% | 27.76% | -0.71% | 1.88% |
Total Preferred Equity | 2.13% | 0.71% | 7.69% | -43.48% | 1.32% |
Total Minority Interest | 441.41% | -- | -- | -- | -- |
Total Equity | 15.08% | -10.08% | 27.82% | -0.85% | 1.89% |
|